Cargando…
Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting
PURPOSE: It has been reported that intravitreal Ziv-aflibercept is a safe and effective drug for the treatment of diabetes macular edema (DME). The objective of this study was to evaluate in a real-life setting, the efficacy of intravitreal Ziv-aflibercept in the treatment of DME after the administr...
Autores principales: | Munayco-Guillén, Fernando, Vazquez-Membrillo, Miguel Angel, Garcia-Roa, Marlon Rafael, De La Cruz-Vargas, Jhony Alberto, García-Perdomo, Herney Andrés, Pichardo-Rodriguez, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106786/ https://www.ncbi.nlm.nih.gov/pubmed/37077223 http://dx.doi.org/10.2147/OPTH.S398359 |
Ejemplares similares
-
Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose, Remya, et al.
Publicado: (2016) -
Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion
por: Chhablani, Jay
Publicado: (2015) -
Comment on: Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion
por: Sen, Alok, et al.
Publicado: (2015) -
Role of peripheral pan-retinal photocoagulation in diabetic macular edema treated with intravitreal ziv-aflibercept
por: Mansour, Ahmad M, et al.
Publicado: (2019) -
Ziv-aflibercept in macular disease
por: Mansour, Ahmad M, et al.
Publicado: (2015)